First do no harm-beware the risk of therapeutic plasma exchange in severe COVID-19

Crit Care. 2020 Jun 18;24(1):363. doi: 10.1186/s13054-020-03070-7.

Authors

Klaus Stahl¹, Christian Bode², Sascha David³

Affiliations

¹ Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
² Department of Anaesthesiology and Critical Care, University Medicine Bonn, Bonn, Germany.
³ Department of Nephrology and Hypertension, Hannover Medical School, Carl-Neuberg-Str.1, 30625, Hannover, Germany. david.sascha@mh-hannover.de.

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections*
Coronavirus*
Humans
Pandemics
Plasma Exchange
Pneumonia, Viral
SARS-CoV-2